Kamel Ihab R, Bluemke David A
Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins Hospital, 600 N. Wolfe Street, Room 100, Baltimore, MD 21287, USA.
J Vasc Interv Radiol. 2002 Sep;13(9 Pt 2):S173-84. doi: 10.1016/s1051-0443(07)61784-9.
Hepatocellular carcinoma (HCC) is one of the most common causes of cancer death worldwide. Numerous surgical and nonsurgical treatment options are available for treating patients with HCC. Successful long-term outcome is dependent on early detection and accurate delineation of the number and location of tumor nodules. Noninvasive imaging modalities, including ultrasound, computed tomography, magnetic resonance imaging, and positron emission tomography, are commonly used in the initial evaluation of these patients. Herein, the authors present the different manifestations of HCC with these imaging modalities and the role of imaging in the follow-up of patients after nonsurgical treatment.
肝细胞癌（HCC）是全球癌症死亡的最常见原因之一。有多种手术和非手术治疗方案可用于治疗HCC患者。长期治疗成功取决于早期检测以及对肿瘤结节数量和位置的准确界定。包括超声、计算机断层扫描、磁共振成像和正电子发射断层扫描在内的非侵入性成像方式常用于这些患者的初始评估。在此，作者介绍了HCC在这些成像方式下的不同表现以及成像在非手术治疗后患者随访中的作用。
